Consistent with the ability to inhibit migration and survival of cancer cells in vitro and xenograft growth in vivo8-12, our data indicate that 10D7 and 41-2 bind extracellularly to CDCP1 within the region spanned by residues 30 to 358. The gene discussed is CDCP1; the disease is cancer.